Summary CONSOL Energy Inc. (CONSOL Energy) is a diversified energy company that produces natural gas and coal. It carries out coal bed methane extraction, conventional and shale gas exploration and production. The company produces Shallow oil and gas, Upper Devonian, Chattanooga, and Huron shale; and Marcellus, Utica, Coalbed Methane. CONSOL Energy also provides various energy services including coal terminal services at the Baltimore terminal, water services, and land resource management services. It serves electricity generators and steelmakers across North America, Europe, South America, and other. The company operates, develops and explores natural gas primarily in Appalachia including West Virginia, Ohio, Pennsylvania, Virginia, and Tennessee; and has interests in Marcellus shale acreage, and delineation and development of Utica Shale acreage. CONSOL Energy is headquartered in Canonsburg, Pennsylvania, the US.
Consol Energy Inc. (CNX) - Power - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Power eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Thalassemia - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H2 2020, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape. Thalassemia is a group of inherited blood disorders...
Meniere Disease - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Meniere Disease - Pipeline Review, H2 2020, provides an overview of the Meniere Disease (Ear Nose Throat Disorders) pipeline landscape. Meniere disease is a disorder of the inner...
Global Psychiatry Partnering 2014 to 2020 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Trends in Psychiatry partnering deals Financial deal terms for headline, upfront and royalty by stage of development Psychiatry partnering...
169 pages •
By Global Industry Analysts
• Sep 2020
Global Personal and Entry Level Storage (PELS) Market to Reach US$272.3 Billion by the Year 2027 Amid the COVID-19 crisis, the global market for Personal and Entry Level Storage (PELS) estimated at US$38.1 Billion in the year 2020, is projected to reach a revised size of US$272.3 Billion by 2027, growing at a CAGR of 32.4% over the...
Global Big Pharma Partnering Terms and Agreements 2014 to 2020 report provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes. This report provides...
This IDC study presents a five-year forecast for the U.S. laser A3/A4 MFP market."Office closures due to COVID-19 are hitting A3 MFP sales harder than A4. Despite a small rebound for A3 in 2021, A4 will gain share across the forecast period, continuing a long-term trend, with A4 color laser providing the greatest opportunity for growth." --...
Human Cytomegalovirus Envelope Glycoprotein B - Pipeline Review, H2 2020 Summary Human Cytomegalovirus Envelope Glycoprotein B (gB) - Human Cytomegalovirus envelope glycoprotein B plays an important role in host cell entry and cell to cell virus transmission. It is involved in the initial attachment...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.